Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer

International Journal of Cancer

Volumn 120, Issue 1, 2007, Pages 81-90

  Wang Johanning, Feng ^a,b   Liu, Jinsong ^b   Rycaj, Kiera ^a   Huang, Miao ^a   Tsai, Kate ^a   Rosen, Daniel G ^b   Chen, Dung Tsa ^c   Lu, Danielle W ^d   Barnhart, Kirstin F ^a   Johanning, Gary L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d HUNTINGTON MEMORIAL HOSPITAL   (United States)

Author keywords

Anti HERV antibodies; Human endogenous retroviruses; Ovarian cancer; Surface envelope proteins; Tumor targets

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ARTICLE; CANCER GRADING; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HERV GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY ADENOCARCINOMA; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS GENE;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; BASE SEQUENCE; CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; CYSTADENOCARCINOMA, SEROUS; ENDOGENOUS RETROVIRUSES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE PRODUCTS, ENV; HUMANS; IMMUNOENZYME TECHNIQUES; MEMBRANE PROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; OVARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED;

EID: 33845456646     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22256     Document Type: Article

References (56)

1. Lander ES, Linton LM, Birren B, Nasbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Fonke R, Gage D et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
2. Hughes JF, Coffin JM. Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution. Nat Genet 2001;29:487-9.
3. Griffiths DJ. Endogenous retroviruses in the human genome sequence. Genome Biol 2001;2:REVIEWS1017.
4. Andersson AC, Yun Z, Sperber GO, Larsson E, Blomberg J. ERV3 and related sequences in humans: structure and RNA expression. J Virol 2005;79:9270-84.
5. Bessis D, Moles JP, Basset-Seguin N, Tesniere A, Arpin C, Guilhou JJ. Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin. Br J Dermatol 2004;151:737-45.
6. Dewannieux M, Blaise S, Heidmann T. Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses. J Virol 2005;79:15573-7.
7. Blaise S, de Parseval N, Benit L, Heidmann T. Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution. Proc Natl Acad Sci USA 2003;100:13013-8.
8. Blaise S, Ruggieri A, Dewannieux M, Cosset FL, Heidmann T. Identification of an envelope protein from the FRD family of human endogenous retroviruses (HERV-FRD) conferring infectivity and functional conservation among simians. J Virol 2004;78:1050-4.
9. Jern P, Lindeskog M, Karlsson D, Blomberg J. Full-length HERV-H elements with env SU open reading frames in the human genome. AIDS Res Hum Retroviruses 2002;18:671-6.
10. de Parseval N, Lazar V, Casella JF, Benit L, Heidmann T. Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins. J Virol 2003;77:10414-22.
11. O'Connell C, O'Brien S, Nash WG, Cohen M. ERV3, a full-length human endogenous provirus: chromosomal localization and evolutionary relationships. Virology 1984;138:225-35.
12. O'Connell CD, Cohen M. The long terminal repeat sequences of a novel human endogenous retrovirus. Science 1984;226:1204-6.
13. Cohen M, Powers M, O'Connell C, Kato N. The nucleolide sequence of the env gene from the human provirus ERV3 and isolation and characterization of an ERV3-specific cDNA. Virology 1985;147:449-58.
14. de Parseval N, Heidmann T. Physiological knockout of the envelope gene of the single-copy ERV-3 human endogenous retrovirus in a fraction of the Caucasian population. J Virol 1998;72:3442-5.
15. Andersson AC, Merza M, Venables P, Ponten F, Sundstrom J, Cohen M, Larsson E. Elevated levels of the endogenous retrovirus ERV3 in human sebaceous glands. J Invest Dermatol 1996;106:125-8.
16. Boyd MT, Bax CM, Bax BE, Bloxam DL, Weiss RA. The human endogenous retrovirus ERV-3 is upregulated in differentiating placental trophoblast cells. Virology 1993;196:905-9.
17. Li JM, Fan WS, Horsfall AC, Anderson AC, Rigby S, Larsson E, Venables PJ. The expression of human endogenous retrovirus-3 in fetal cardiac tissue and antibodies in congenital heart block. Clin Exp Immunol 1996;104:388-93.
18. Larsson E, Andersson AC, Nilsson BO. Expression of an endogenous retrovirus (ERV3 HERV-R) in human reproductive and embryonic tissues - evidence for a function for envelope gene products. Ups J Med Sci 1994;99:113-20.
19. Katsumata K, Ikeda H, Sato M, Ishizu A, Kawarada Y, Kato H, zWakisaka A, Koike T, Yoshiki T. Cytokine regulation of env gene expression of human endogenous retrovirus-R in human vascular endothelial cells. Clin Immunol 1999;93:75-80.
20. Kitamura M, Maruyama N, Shirasawa T, Nagasawa R, Watanabe K, Tateno M, Yoshiki T. Expression of an endogenous retroviral gene product in human placenta. Int J Cancer 1994;58:836-40.
21. Turbeville MA, Rhodes JC, Hyams DM, Distler CM, Steele PE. Expression of a putative immunosuppressive protein in human tumors and tissues. Pathobiology 1996;64:233-8.
22. Aguinaldo AM, Turbeville JM, Linford LS, Rivera MC, Garey JR, Raff RA, Lake JA. Evidence for a clade of nematodes, arthropods and other moulting animals. Nature 1997;387:489-93.
23. Lower R, Boller K, Hasenmaier B, Korbmacher C, Muller-Lantzsch N, Lower J, Kurth R. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci USA 1993;90:4480-4.
24. Lower R, Lower J, Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci USA 1996;93:5177-84.
25. Lower R, Tonjes RR, Korbmacher C, Kurth R, Lower J. Identification of a Rev-relaled protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J Virol 1995;69:141-9.
26. Seifarth W, Skladny H, Krieg-Schneider F, Reichert A, Hehlmann R, Leih-Mosch C. Retrovirus-like particles released from the human breast cancer cell line T47-D display type B- and C-related endogenous retroviral sequences. J Virol 1995;69:6408-16.
27. Etkind PR, Lumb K, Du J, Racevskis J. Type I HERV-K genome is spliced into subgenomic transcripts in the human breast tumor cell line T47D. Virology 1997;234:304-8.
28. Willer A, Saussele S, Gimbel W, Seifarth W, Kister P, Leib-Moseh C, Hehlmann R. Two groups of endogenous MMTV related retroviral env transcripts expressed in human tissues. Virus Genes 1997;15:123-33.
29. Wang-Johanning F, Frost AR, Johanning GL, Khazaeli MB, LoBuglio AF, Shaw DR, Strong TV. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer. Clin Cancer Res 2001;7:1553-60.
30. Ono M, Kawakami M, Ushikubo H. Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J Virol 1987;61:2059-62.
31. Magin C, Hesse J, Lower J, Lower R, Corf. the Rev/Rex homologue of HTDV/HERV-K, encodes an arginine-rich nuclear localization signal that exerts a trans-dominant phenotype when mutated. Virology 2000;274:11-6.
32. Magin C, Lower R, Lower J, cORF and RcRE, the Rev/Rex and RRE/RxRE homologues of the human endogenous retrovirus family HTDV/HERV-K. J Virol 1999;73:9496-507.
33. Yang J, Bogerd HP, Peng S, Wiegand H, Truant R, Cullen BR. An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein. Proc Natl Acad Sci USA 1999;96:13404-8.
34. Boese A, Sauter M, Galli U, Best B, Herbst H, Mayer J, Kremmer E, Roemer K, Mueller-Lantzsch N. Human endogenous retrovirus protein cORF supports cell transformation and associates wilth the promyelocytic leukemia zinc finger protein. Oncogene 2000;19:4328-36.
35. Boese A, Sauter M, Mueller-Lantzsch N, A Rev-like NES mediates cytoplasmic localization of HERV-K cORF. FEBS Lett 2000;468:65-7.
36. Wang-Johanning F. Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene 2003;22:1528-35.
37. Wang-Johanning F, Frost AR, Jian B, Azerou R, Lu DW, Chen DT, Johanning GL. Detecting the expression of human endogenous retrovirus E envelope transcripts in human prostate adenocarcinoma. Cancer 2003;98:187-97.
38. Liu J, Yang G, Thompson-Lanza JA, Glassman A, Hayes K, Patterson A, Marquez RT, Auersperg N, Yu Y, Hahn WC, Mills GB, Bast RC, Jr. A genetically defined model for human ovarian cancer. Cancer Res 2004;64:1655-63.
39. Mayer J, Sauter M, Racz A, Scherer D, Mueller-Lantzsch N, Meese E. An almost-intact human endogenous retrovirus K or human chromosome 7. Nat Genet 1999;21:257-8.
40. Armbruester V, Sauter M, Krautkraemer E, Meese E, Kleiman A, Best B, Roemer K, Mueller-Lantzsch N. A novel gene from the human endogenous retrovirus K expressed in transformed cells. Clin Cancer Res 2002;8:1800-7.
41. Wang-Johanning F, Lu DW, Wang Y, Johnson MR, Johanning GL. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis. Cancer 2002;94:2199-210.
42. Wang-Johanning F, Gillespie GY, Grim J, Rancourt C, Alvarez RD, Siegal GP, Curiel DT. Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects. Cancer Res 1998;58:1893-900.
43. Tonjes RR, Lower R, Boller K, Denner J, Hasenmaier B, Kirsch H, Konig H, Korbmacher C, Limbach C, Lugert R, Phelps RC, Scherer J et al. HERV-K: the biologically most active human endogenous retrovirus family. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:S261-7.
44. Galli UM, Sauter M, Lecher B, Maurer S, Herbst H, Roemer K, Mueller-Lantzsch N. Human endogenous retrovirus rec interferes with germ cell development in mice and may cause carcinoma in situ, the predecessor lesion of germ cell tumors. Oncogene 2005;24:3223-8.
45. Kato N, Pfeifer-Ohlsson S, Kato M, Larsson E, Rydnert J, Ohlsson R, Cohen M. Tissue-specific expression of human provirus ERV3 mRNA in human placenta: two of the three ERV3 mRNAs contain human cellular sequences. J Virol 1987;61:2182-91.
46. Florl AR, Lower R, Schmitz-Drager BJ, Schutz WA. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer 1999;80:1312-21.
47. Menendez L, Benigno BB, McDonald JF, LI and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas. Mol Cancer 2004;3:12.
48. Seifarth W, Frank O, Zeilfelder U, Spiess B, Greenwood AD, Hehlmann R, Leib-Mosch C. Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray. J Virol 2005;79:341-52.
49. Buscher K, Trefzer U, Hofmann M, Sterry W, Kurth R, Denner J. Expression of human endogenous retvovirus K in melanomas and melanoma cell lines. Cancer Res 2005;65:4172-80.
50. Holland CA, Hartley JW, Rowe WP, Hopkins N. At least four viral genes contribute to the leukemogenicity of murine retrovirus MCF 247 in AKR mice. J Virol 1985;53:158-65.
51. Britten RJ. Coding sequences of functioning human genes derived entirely from mobile element sequences. Proc Natl Acad Sci USA 2004;101:16825-30.
52. Lower R. The pathogenic potential of endogenous retroviruses: facts and fantasies. Trends Microbiol 1999;7:350-6.
53. de Parseval N, Alkabbani H, Heidmann T. The long terminal repeats of the HERV-H human endogenous retrovirus contain binding sites for transcriptional regulation by the Myb protein. J Gen Virol 1999;80(Part 4):841-5.
54. Lee WJ, Kwun HJ, Kim HS, Jang KL. Activation of the human endogenous retrovirus W long terminal repeat by herpes simplex virus type 1 immediate early protein 1. Mol Cells 2003;15:75-80.
55. Sjottem E, Anderssen S, Johansen T. The promoter activity of long terminal repeats of the HERV-H family of human retrovirus-like elements is critically dependent on Sp1 family proteins interacting with a GC/GT box located immediately 3′ to the TATA box. J Virol 1996;70:188-98.
56. Lavie L, Kitova M, Maldener E, Meese E, Mayer J. CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2). J Virol 2005;79:876-83.